Published in Cardiovascular Business Week, June 28th, 2005
Together with other existing shareholders, NeuroSearch has completed an increase of Sophion's capital base of (Denmark kroner) DKK20 million (US$2.26 million). NeuroSearch has participated with DKK6.4 million (US$1.05 million) and thereby increased its ownership from 25% to 29%.
This strengthening of Sophion's capital base is to ensure the company's future growth and primarily be used for the up-scaling of the company's production of QPatch16...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.